NCT03285126View on ClinicalTrials.gov

Pompe Gene Therapy- Screening for Eligibility

CompletedOBSERVATIONAL

Enrollment

19

Participants

Timeline

Start Date

November 1, 2017

Primary Completion Date

June 29, 2019

Study Completion Date

June 29, 2019

Conditions

Pompe Disease (Late-onset)

Trial Locations (1)

27701

Duke University Medical Center, Durham

Sponsors

Lead Sponsor

Duke University

All Listed Sponsors

lead

Duke University

OTHER

NCT03285126 - Pompe Gene Therapy- Screening for Eligibility | Biotech Hunter | Biotech Hunter